Sean Johnston, Ph.D., J.D., Board Chair, Senior Vice President and
Carla Boragno, Vice President, SSF Site Services
Vishva Dixit, M.D., Vice President, Physiological Chemistry
Chris Horan, Senior Vice President, Global Product and Supply Chain Management
Sara Kenkare-Mitra, Ph.D., Senior Vice President, Development Sciences
Frank Lee, Senior Vice President, Global Product Strategy, Therapeutic Area Head, I2O
Nancy Oaks, Vice President, Hematology Franchise
Eric J. Olson, Vice President, US Product Development Regulatory, Genentech, Inc.
Mary B. Sliwkowski, Ph.D., Senior Vice President, Pharma Technical Regulatory
Geoff Teeter, Vice President, Corporate Relations
Sean Johnston started working in Genentech’s legal department in 1987 as an intern and joined the department as a regular employee in 1990. After holding various positions there, in 1998 he was named Vice President, Intellectual Property, and in 2007 he was named Senior Vice President and General Counsel. He manages Genentech’s in-house legal staff of over 100 attorneys and patent agents, who are responsible for Genentech’s intellectual property, corporate law, and litigation matters.
Prior to his employment with Genentech, Sean was law clerk to Judge Wm. Matthew Byrne, Jr. in the U.S. District Court, Central District of California in Los Angeles. Before that, he was a research scientist at International Genetic Engineering, Inc./Xoma Ltd.
Sean received a Bachelor of Science degree in biochemistry from the University of California, Davis and a Ph.D. in molecular biology from the University of California, Los Angeles. He also holds a J.D. with Honors from Stanford Law School.
Carla Boragno is a transformational business leader known for delivering results, scaling organizations for growth, and building high-performing global teams. Carla is a true change agent, with a passion for motivating and inspiring talent. Carla's expertise across multiple disciplines (including engineering, manufacturing, procurement, IT and M&A integration) and her track record of success over 25+ years makes her a natural choice to lead large-scale, cross-functional organizations and initiatives that require innovative solutions and making good teams great.
In Carla’s current role as Vice President of Site Services she is accountable for Genentech’s corporate real estate portfolio, physical infrastructure, and several key workplace services for the South San Francisco campus. This progressive biotechnology campus consists of approximately 9,000 employees, 180 acres, and over 5 million square feet of space devoted to research and development, manufacturing, marketing and administration.
Prior to her current role, Carla has held numerous leadership positions across functions and geographies. As Head of Procurement Services for Roche’s Global Pharma Procurement organization, she was responsible for strategic and operational procurement services across Roche. While based in Singapore, Carla led the transition and full integration of a newly acquired manufacturing facility into Genentech’s existing Singapore operations. Carla also had responsibility for the implementation of a $1.5B capital design and construction portfolio during peak growth at Genentech.
Carla holds a Bachelor of Science, Chemical Engineering from University of California, Berkeley. Carla is a mentor to many within and outside Genentech, and is sought after as an inspirational speaker. She also serves on the Board of Directors for Northern California Junior Achievement and the Genentech Foundation. Outside of work, she can be found working in her kitchen and garden, and volunteering at her daughter’s school.
Vishva Dixit is Vice President of Physiological Chemistry at Genentech. In this role, he leads the Department of Physiological Chemistry's efforts in basic research to study the biochemistry of components of signaling pathways that often go awry in disease. Vishva has published well over a hundred scientific articles. He also has a significant number of patents to his name. He previously held the position of Vice President, Research, Molecular Oncology, where he was responsible for overseeing Genentech's research programs focused on understanding the biology of cancer, discovering novel oncology therapeutics and moving projects into the drug development pipeline. Vishva joined Genentech in 1997 as the Director of the Molecular Oncology department.
Prior to joining Genentech, Vishva joined the Department of Pathology at the University of Michigan Medical School as an Assistant Professor before being appointed to Full Professor in 1995. His laboratory published a series of groundbreaking papers in the mid-nineties that defined the molecular components of the cell death receptor pathway. Vishva was awarded the Warner-Lambert/Parke David Award in Experimental Pathology in 1996, has published more than 100 scientific articles and holds a significant number of patents. Vishva continues to teach as an adjunct Professor in the Department of Pharmaceutical Chemistry at the University of California, San Francisco.
Vishva received his medical degree from the University of Nairobi in Nairobi, Kenya. Following an internship at Kenyatta National Hospital, he pursued further medical training as a resident at the Department of Laboratory Medicine at Washington University School of Medicine and as a postdoctoral fellow in the University's Department of Biological Chemistry.
He is a Foreign Member, European Molecular Biology Organization, a member of the Institute of Medicine, the American Academy of Arts and Sciences and the National Academy of Sciences.
Chris Horan is Senior Vice President, Global Product and Supply Chain Management. He joined Genentech in 2004 to launch Business Process Excellence and moved to Supply Chain Planning in 2006 where he was subsequently appointed to lead planning, distribution and logistics in 2007. In 2009, Chris was appointed Head of North American Supply Chain and PT Business Process Excellence. From 2011 to 2013, Chris led Tech Ops Procurement, responsible for Pharma-wide direct materials, contract manufacturing and global engineering spend. Since 2013, he has been has been leading the Global Product and Supply Chain Management organization for Roche Pharma. Chris has a total of 28 years of experience in the biopharmaceutical industry, including his 16 years with Merck & Co., Inc. His career has included international assignments in seven countries on five continents. Chris holds a Bachelors of Engineering from Stevens Institute of Technology, Hoboken, New Jersey.
Sara Kenkare-Mitra is currently Senior Vice President of Development Sciences, a translational sciences organization that spans R&D at Genentech. In this role she has responsibility for ensuring the successful translation of promising molecule-discoveries from Research into Development.
Sara has had a significant impact on the development of a number of biologics and small molecules leading to Genentech's key product approvals. In addition, more than 60 Investigational New Drug applications with potential to treat a multitude of diseases in particular cancer, have been filed by her organization with US and ex-US regulatory agencies. At Genentech she is a key member of the technical and portfolio decision-making committees. Scientifically, she has played a key role on a number of programs at Genentech, but most notably in the early optimization and re-tooling of the antibody drug conjugate platform leading to the discovery of Genentech's first antibody-drug conjugate targeting cancer.
Sara has an educational background in Pharmacy (B Pharm, India), Ph.D. in Pharmaceutical Chemistry from UCSF and a post-doctoral fellowship in Clinical Pharmacology from UCSF. Sara is an adjunct Full Professor at UCSF in the Department of Bioengineering and Therapeutic Sciences and an adjunct faculty at the University of the Pacific in Stockton. Sara was elected to the Institute of Medicine, the National Academy of Sciences in 2014. Selected as one of the 150 Most Influential Business women by San Francisco Business times, she has also won awards and recognition at Genentech not only for her excellence in leadership and mentorship, but also for her passionate commitment to the healthcare industry as a whole. She is a steering committee chair for gWISE (Genentech Women in Science and Engineering) and an advisor for SANG (South Asian Network at Genentech) and gSPECTRUM (People with disabilities) and a mentor through a number of mentoring programs at Genentech.
Frank Lee currently serves as Senior Vice President in the GPS organization, where he heads the Immunology, Infectious Diseases and Ophthalmology therapy area. Prior to GPS, Frank was VP of the HER2 Franchise, where he had commercial responsibility for the breast cancer portfolio.
Frank joined Genentech in 2006, and has held positions of increasing responsibility within the US Commercial Organization including Marketing Director, Franchise Head and VP of Oral Oncolytics Sales and Marketing.
Before coming to Genentech, Frank was Executive Director in the Ophthalmics Business Unit at Novartis. Prior to Novartis, Frank served in roles of increasing responsibility within sales, marketing, business development, and manufacturing at Johnson & Johnson and Eli Lilly.
Frank earned an MBA from the Wharton Graduate School of Business at the University of Pennsylvania and a Bachelor of Science in Chemical Engineering from Vanderbilt University.
Nancy Oaks serves as Vice President, Hematology Franchise. In this role, Nancy is responsible for all aspects of Genentech's U.S. hematology business. She joined Genentech in August 2006 as a National Sales Director. She then held positions of increasing responsibility in Genenetch's Managed Care and Primary Care organizations.
Prior to joining Genentech, Nancy worked at Stiefel Laboratories as Vice President of Sales. She was also formerly with Amgen, where she held a variety of sales, operations, and marketing research positions.
Nancy holds business degrees from the Lubin School of Business at Pace University.
Eric J. Olson is Vice President, US Product Development Regulatory for Genentech. He is responsible for US Regulatory Policy and Intelligence, overseeing the company’s US Commercial Regulatory Affairs organization, and serving as US PDR site head. While previously based in Basel, Switzerland, Eric served as business lead for Roche Product Development’s Smart Information Management initiative, a multi-year innovation project aimed at transforming how the company manages its vast clinical information. Eric has held roles as Genentech’s head of Commercial Regulatory Affairs where he managed the team responsible for reviewing and approving product marketing and advertising materials and Roche’s REMS and SSF labeling groups, Director of PD Projects for Genentech’s former President Sue Desmond-Hellmann and as one of the company’s federal lobbyists.
Prior to joining Genentech, Eric was Chief of Staff to U.S. Representative Anna G. Eshoo - managing all aspects of her Washington, D.C. legislative office. Eric also held positions with former U.S. Senate Democratic Leader Thomas Daschle and Rep. Norm Mineta.
Eric graduated from Santa Clara University in 1995 with a B.A. in Political Science and minor in Communication. Eric’s wife Kristin and two daughters live in Redwood City, CA. Hobbies include reading, coaching his daughters’ sports teams, distance running and learning more and more about wine.
Mary Sliwkowski is Senior Vice President, Pharma Technical Regulatory. In this role, she oversees the technical regulatory activities for all global development and marketed products.
Mary joined Genentech in 1985 after completing a postdoctoral fellowship at the National Institutes of Health (NIH). She went on to hold positions of increasing responsibility in a variety of organizations within the company, including Cell Culture Process Sciences, Analytical Chemistry, Quality Control, Corporate Quality and Regulatory.
Mary holds a bachelor's of science degree in Chemistry from the University of Delaware and a doctorate in Biochemistry from North Carolina State University.
Geoffrey P. Teeter is Vice President, Corporate Relations at Genentech. In this role, he oversees the activities of the Corporate Relations department including corporate communications, digital communications and integrated brand management, internal communications, corporate and employee giving, and product public relations.
Geoff joined Genentech in 1993 as a Manager, Corporate Communications. During his time at the company, he has developed and implemented a number of communications initiatives and strategies that have helped strengthen Genentech's corporate reputation and supported the company's goal of being a great place to work.
Prior to joining Genentech, Geoff worked on behalf of several pharmaceutical and healthcare companies at Burson-Marsteller in Manhattan, and as a product communications manager at CIBA-Geigy Pharmaceuticals Division.
Geoff holds a bachelor's degree in mass communication from St. Bonaventure University.